Clinical trial · Interventional
Pilot Study of 18F-FLT PET
Pilot Study of 18F-FLT Pet Imaging in Cancer Patients
NCT00585741CI-TRIAL-00006322terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CNS Brain Metastasis | — | UNRESOLVED | — |
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Imaging with 18F-FLT PET | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- type
- EXPERIMENTAL
- label
- 2. Head and neck
- description
- Imaging with 18F-FLT PET
- interventionNames
- Procedure: Imaging with 18F-FLT PET
- type
- EXPERIMENTAL
- label
- 3. Lung
- description
- Imaging with 18F-FLT PET
- interventionNames
- Procedure: Imaging with 18F-FLT PET
- type
- EXPERIMENTAL
- label
- 4. prostate
- description
- Imaging with 18F-FLT PET
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Able to tolerate a PET/CT scan * Age of 18 or older * signed informed consent * being considered for radiotherapy for treatment of CNS mets, Head and neck cancer, lung cancer, prostate cancer or esophageal cancer Exclusion Criteria: * Prior XRT to site being studied * severe claustrophobia or inability to tolerate PET/CT * unable to provide written consent * pregnant or breastfeeding women
References
Publications (0)
Data not yet available
No reference posted for this study.